// App-Quantinova.ai

231 : In Adult Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia, The Negative Prognostic Impact Of IKZF1, CDKN2A/B and PAX5 Deletions Is Not Abrogated By Allogeneic Stem Cell Transplantation In First Complete Remission

Researchers

Presenter

  • Heike Pfeifer

Principal Investigators

  • Katharina Raum

  • Sandra Markovic

  • Oliver G. Ottmann

  • Daniel Nowak

  • Stephanie Fey

  • Julia Oblander

  • Verena Nowak

  • Wunderle Lydia

  • Fabian Lang

  • Dieter Hoelzer

  • Wolf-Karsten Hofmann

  • Nicola Goekbuget

Medical Centers

  • Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany

  • Department of Medicine, Hematology/Oncology, Goethe University of Frankfurt, Frankfurt, Germany

  • Department of Hematology and Oncology, University Hospital, Rostock, Germany

  • Department of Hematology/Oncology, Goethe-University Hospital Frankfurt, Frankfurt Am Main, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Paired box 5

  • Cyclin dependent kinase 2

  • Cyclin Dependent Kinase Inhibitor 2A

  • Retinoblastoma protein

  • ETV6-RUNX1

Drug/Treatment

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved